- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Relugolix and Enzalutamide
Total 273334 results
-
NYU Langone HealthRecruitingProstate CancerUnited States
-
PfizerNot yet recruiting
-
Boehringer IngelheimCompletedProstatic Neoplasms, Castration-ResistantKorea, Republic of, United States, Spain, Taiwan, United Kingdom, Singapore, Hong Kong, Netherlands
-
Astellas Pharma Europe B.V.Medivation, Inc.CompletedMetastatic Castration-Resistant Prostate CancerBelgium, France, Germany, Spain, United Kingdom
-
Astellas Pharma Europe B.V.Medivation, Inc.CompletedSevere Hepatic Impairment | Normal Hepatic FunctionBulgaria
-
University of SydneyCanadian Cancer Trials Group; Australian and New Zealand Urogenital and Prostate... and other collaboratorsActive, not recruitingProstatic NeoplasmsNew Zealand, Canada, United States, Australia, United Kingdom, Ireland
-
Cedars-Sinai Medical CenterCompletedProstate CancerUnited States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration-Resistant Prostate CancerUnited States, Canada, France, Spain, United Kingdom, Australia, Poland, Germany, Austria, Belgium, Netherlands, Italy, Chile, South Africa, Argentina
-
Astellas Pharma Global Development, Inc.Medivation, Inc.Approved for marketingMetastatic Castration-Resistant Prostate Cancer
-
University Health Network, TorontoAstellas Pharma IncActive, not recruitingMetastatic Prostate CancerCanada
-
Main Line HealthPfizer; Sumitomo Pharma America, Inc.Not yet recruitingEndometriosisUnited States
-
ORIC PharmaceuticalsTerminated
-
BayerCompletedNon-metastatic Prostate Cancer | Non-metastatic Castration-resistant Prostate CancerUnited States
-
Veru Inc.TerminatedMetastatic Castration-resistant Prostate Cancer | Androgen Resistant Prostatic CancerUnited States
-
Zenith EpigeneticsAstellas Pharma Inc; Newsoara Biopharma Co., Ltd.RecruitingMetastatic Castration-Resistant Prostate CancerUnited States, China
-
Radboud University Medical CenterAstellas Pharma Europe B.V.CompletedMetastatic Castration Resistant Prostate CancerNetherlands
-
National Cancer Institute (NCI)TerminatedProstate Neoplasms | Metastatic Castration Resistant Prostate CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI); National Comprehensive Cancer NetworkTerminatedRecurrent Mantle Cell Lymphoma | Refractory Mantle Cell Lymphoma | Ann Arbor Stage I Mantle Cell Lymphoma | Ann Arbor Stage II Mantle Cell Lymphoma | Ann Arbor Stage III Mantle Cell Lymphoma | Ann Arbor Stage IV Mantle Cell LymphomaUnited States
-
University of ChicagoNational Cancer Institute (NCI); Corcept TherapeuticsRecruitingProstate CancerUnited States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration Resistant Prostate Cancer | Prostate Carcinoma Metastatic to the BoneUnited States
-
Astellas Pharma Global Development, Inc.Medivation, Inc.TerminatedMetastatic Castration Resistant Prostate CancerUnited States
-
TakedaCompletedHormone Treatment-naïve Participants With Prostate CancerJapan
-
Myovant Sciences GmbHCompleted
-
Eli Lilly and CompanySarah Cannon Development InnovationsCompletedProstate Cancer MetastaticUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)TerminatedClear Cell Renal Cell Carcinoma | Stage I Renal Cell CancerUnited States
-
Royal Marsden NHS Foundation TrustUniversity College, London; The Leeds Teaching Hospitals NHS Trust; Belfast Health... and other collaboratorsUnknownProstate Cancer | Metastasis | Toxicity Due to Radiotherapy | Circulating Tumour DNAUnited Kingdom
-
PfizerAstellas Pharma IncActive, not recruitingmCRPCChina, Finland, Spain, United States, Hungary, Israel, Belgium, Korea, Republic of, France, Canada, Czechia, Australia, Japan, Brazil, Germany, Argentina, New Zealand, United Kingdom, Norway, South Africa, Poland, Portugal, Chile, Italy, Pe... and more
-
Progenics Pharmaceuticals, Inc.Active, not recruitingCastration-resistant Prostate Cancer | Metastatic Prostate Cancer | Cancer of the Prostate | Prostatic Neoplasm | Progressive mCRPCUnited States, Canada
-
TakedaCompleted
-
AbbVieCompletedEndometriosis, Pain
-
University of Southern CaliforniaUnknown
-
Swiss Group for Clinical Cancer ResearchTerminatedProstate Cancer | Cancer of the ProstateSwitzerland
-
British Columbia Cancer AgencySanofi; Ozmosis Research Inc.UnknownMetastatic Castration-Resistant Prostatic CancerCanada, Australia
-
Yale UniversityJohns Hopkins University; University of Colorado, Denver; Northwestern University and other collaboratorsRecruitingInfertility | EndometriosisUnited States
-
PfizerAstellas Pharma IncActive, not recruitingProstate CancerUnited States, Finland, China, France, Spain, Hungary, United Kingdom, Korea, Republic of, Canada, Czechia, Taiwan, Belgium, Australia, Argentina, Japan, Germany, India, Turkey, Slovakia, Russian Federation, Bulgaria, Italy, Ukraine, ... and more
-
Janssen Research & Development, LLCCompleted
-
Hoffmann-La RocheCompletedProstatic Neoplasms, Castration-ResistantUnited States, Korea, Republic of, Belgium, United Kingdom, Canada, China, Denmark, France, Greece, Poland, Spain, Italy, Czechia, Japan, Switzerland, Australia, Germany, Austria, Hungary, Russian Federation, Taiwan
-
DendreonCompletedMetastatic Prostate CancerUnited States
-
Sumitomo Pharma Switzerland GmbHNot yet recruitingPregnancy Complications | Pregnancy Related | Pregnancy, High Risk
-
Myovant Sciences GmbHCompleted
-
Yale UniversityUniversity of Colorado, Denver; Eunice Kennedy Shriver National Institute of... and other collaboratorsActive, not recruitingInfertility | EndometriosisUnited States
-
AbbVieCompletedEndometriosis, Pain
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedAdvanced Breast Cancer | HER2 Amplified | Human Epidermal Growth Factor Receptor 2 (HER2)United States, Belgium, Canada, Italy, Spain, United Kingdom
-
Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator...Active, not recruitingProstate CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.; Translational Breast Cancer... and other collaboratorsTerminatedStage IV Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Negative | Progesterone Receptor Positive | Triple-Negative Breast CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma Inc; Medivation, Inc.Active, not recruitingBreast Cancer | Triple Negative Breast Cancer | Early StageUnited States
-
BayerCompletedCerebrovascular CirculationUnited Kingdom
-
TakedaCompleted
-
Millennium Pharmaceuticals, Inc.CompletedProstate CancerUnited States, United Kingdom
-
PfizerAstellas Pharma IncCompletedProstatic NeoplasmsUnited States